RNAx Ltd. is rated 3 out of 5 in the category innovative for advanced therapies. Read and write reviews about RNAx Ltd.. RNAx Platforms: RNAVac: RNA Mono/Multivalent Vaccine platform (Cancer, Viral, and Microbial pathogen) RNABiosimilars: RNA-based Biosimilar for off-patent protein drugs RNAiX: Next generation RNA interference products RNAeditas: RNA-based genome editing, epigenome reprogramming, and RNA editing platform RNAmAbs: mRNA platform for mono/multispecies monoclonal antibody RNAReprogramming: RNA mediated in-vitro and in-vivo direct cell reprogramming RNAImmuno: In-vivo and in-vitro RNA mediated CAR/TCR T cells engineering RNAenzyme: mRNA Mediated hormone and large protein replacement (Dystrophin, Factor 8,..) RNA Cosmetics: Innovative beauty and cosmetics products based on RNA RNAx Animal: Pet and Veterinary mRNA Medicine and Nutrition RNAx with focusing on RNA therapy and the employ of the novel targeting RNA delivery platform will provide technology for biopharma companies to replaced protein therapy with RNA therapy. RNA therapy in the next years will form "Next Generation Medicine".
Company size
1-10 employees